Similar Articles
Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus
Yaling CHEN, Yanqing WANG, Xiangfang CHEN, Huishun LIANG, Xuwei YANG
DOI: 10.46497/ArchRheumatol.2020.7583
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases
Andreina MANFREDI, Giulia CASSONE, Caterina VACCHI, Fabrizio PANCALDI, Giovanni Della CASA, Stefania CERRI, Lisa De PASQUALE, Fabrizio LUPPI, Carlo SALVARANI, Marco SEBASTIANI
DOI: 10.46497/ArchRheumatol.2021.7975
A preliminary study of possible fibrotic role of meprin metalloproteases in scleroderma patients
Ayşe Koçak, Aydan Köken Avşar, Duygu Harmancı, Gül Akdoğan, A. Merih Birlik
DOI: 10.46497/ArchRheumatol.2021.8581
Screening and identification of potential biomarkers and therapeutic targets for systemic sclerosis-associated interstitial lung disease
Biqing Huang, Jing Li, Jiuliang Zhao
DOI: 10.46497/ArchRheumatol.2021.8625
Patient perspectives on biological treatments for inflammatory arthritis: A multi-center study in Korea
In Ah Choi, Ji Hyoun Kim, Sung Hae Chang, Ran Song, You-Jung Ha, Hye Won Kim, Jeong Seok Lee, Byoongyong Choi, Yoon-Jeong Oh, Ki Won Moon
DOI: 10.46497/ArchRheumatol.2021.8524
Persistent eosinophilia and associated organ involvement in Thai patients with systemic sclerosis: Data from the Siriraj scleroderma cohort
Somsak Punjasamanvong, Chayawee Muangchan
DOI: 10.46497/ArchRheumatol.2021.8855
Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan
Sadia Asif, Asadullah Khan, Muhammad Faiq, Zia Ud Din, Sarmad Zahoor, Muhammad Haroon
DOI: 10.46497/ArchRheumatol.2021.8701
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
DOI: 10.46497/ArchRheumatol.2023.9636
Analysis of risk factors for the progression and prognosis of connective tissue disease-associated interstitial lung disease
Ting Zhao, Fu-an Lin, Hongpu Chen
DOI: 10.46497/ArchRheumatol.2023.9602
Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis
Fulden Sari, Zilan Bazancir Apaydin, Hakan Apaydin, Mehmet Kayaalp, Abdulsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, Orhan Kucuksahin, Şükran Erten
DOI: 10.46497/ArchRheumatol.2023.10183
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2023.10199
Clinical association study on the matrix metalloproteinase expression in the serum of patients with connective tissue disease complicated with interstitial lung disease
Hong Chen*, Jun Tang*, Juhua Liang, Dan Huang, Chunfeng Pan, Sha Liu, Xiuri Du, Liju Tao
DOI: 10.46497/ArchRheumatol.2023.9547
Males and females with scleroderma: A comparative study in a Brazilian sample
Matheus Costa, Igor Jorge, Patricia Martin, Renato Nisihara, Thelma Skare
DOI: 10.46497/ArchRheumatol.2023.10011
Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study
Jakob Höppner, Maximilian Wollsching-Strobel, Falk Schumacher, Wolfram Windisch, Melanie Berger
DOI: 10.46497/ArchRheumatol.2024.10105